Our background
Discover how we have Evolved our Company’s on Legacy.
Our mission is to empowers businesses off all size to thrive in an businesses ever changing marketplace. We are committed to the delivering exceptional in the value through our strategic inset, innovative approaches. Our mission is to empower businesses of all sizes to thrive.
Committed to the delivering exceptional in the value through our strategic inset, innovative approaches empower.
2024
Incorporation and Founding
- Incorporated as a private limited company, registered in England and Wales.
- Established at Translation and Innovation Hub, 84 Wood Lane, White City, London W12 0BZ.
- Core mission: transforming genetic data into actionable translational insights.
First Engagements and Scientific Foundation
- First client engagements established in pharma and biotech target discovery.
- Core methods established: MR, pQTL, GWAS, colocalization, and PheWAS.
- Academic partnerships initiated for large-scale biobank data access.
2025
Research, Publications and Growing Partnerships
- Scientific publications in human genetics and translational medicine.
- Expanded client base across pharma, biotech, and investor partners.
- Deepened academic consortium relationships.
- Established Sequoia as a recognised specialist genetics consultancy.
2026
Expansion and Diversification: Wulfstan Analytics, Sri Lanka
- Strategic partnership with Wulfstan Analytics, Sri Lanka — March 2026.
- First international operational presence for Sequoia Genetics.
- Expanded data analytics capabilities and international client reach.
- Operational presence established across the UK (London) and Sri Lanka.
NOW
New London Office
- New London office opening on 1 June 2026.
- Expanded premises to support continued team and client growth.
- Continued international operations alongside the Wulfstan Analytics partnership in Sri Lanka.
